EPISODE · Apr 29, 2026 · 4 MIN
Maintenance Immunotherapy in MOGAD: Early Steroid Benefit, Dose Thresholds, and Disability Risk - Part 1
from Neurology Minute · host American Academy of Neurology
In part one of this series, Dr. Justin Abbatemarco and Dr. Benjamin P. Trewin discuss the major findings from his work. Read more about this abstract on the AAN website.
NOW PLAYING
Maintenance Immunotherapy in MOGAD: Early Steroid Benefit, Dose Thresholds, and Disability Risk - Part 1
No transcript for this episode yet
Similar Episodes
May 27, 2026 ·51m
May 13, 2026 ·22m
Apr 30, 2026 ·35m